Brief: FDA Tandem Diabetes Care Issues Correction For Certain TSlim X2 Insulin Pumps
15/09/2025 22:46
Sept 15 (Reuters) - Tandem Diabetes Care Inc TNDM.O: FDA: TANDEM DIABETES CARE ISSUES CORRECTION FOR CERTAIN T:SLIM X2 INSULIN PUMPS DUE TO RISK FOR FAULTY SPEAKER WIRING Source text: [ID:] Further company coverage: TNDM.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tandem Diabetes Care
See all newsU.S. STOCKS ON THE MOVE -VF Corp, Biogen, AbbVie
US STOCKS ON THE MOVE-SpaceX, Humana, AbbVie
U.S. STOCKS ON THE MOVE-SpaceX, Humana, Crescent Energy
MedTech growth concerns likely to overshadow Q3 results, Leerink says
Tandem Diabetes Care, Inc. reports results for the quarter ended June 30 - Earnings Summary